Accuracy of screening for gastric cancer using serum pepsinogen concentrations
Open Access
- 1 May 1999
- Vol. 44 (5) , 693-697
- https://doi.org/10.1136/gut.44.5.693
Abstract
BACKGROUND/AIMS The characteristics of pepsinogen screening for gastric cancer were investigated to establish a suitable cut off point for identifying gastric cancer, using endoscopic diagnosis as the yardstick. SUBJECTS/METHODS Serum pepsinogen concentrations were measured in 5113 subjects who were also screened for gastric cancer by endoscopy. The cut off point for pepsinogen was determined using receiver operator characteristics curves. RESULTS The most suitable cut off point was a pepsinogen I concentration of less than 70 ng/ml and a ratio of pepsinogen I to pepsinogen II of less than 3.0. Using this cut off point, the sensitivity and specificity of pepsinogen screening for gastric cancer were 84.6% and 73.5% respectively. All cases of gastric cancer in patients with severe atrophic gastritis were detected. However, two of four cases of gastric cancer in patients with mild atrophic gastritis were overlooked. In subjects with mild atrophic gastritis, when gastric cancer arises within the fundic gland region, the size of the lesion determines whether it is possible to detect cancer by serum pepsinogen screening. CONCLUSION Pepsinogen screening has many advantages, including its suitability for combination with other screening methods because it is simple and inexpensive.Keywords
This publication has 13 references indexed in Scilit:
- Serum pepsinogen in screening for gastric cancerThe Esophagus, 1995
- The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer ratesGastroenterology, 1994
- Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric CancerJapanese Journal of Cancer Research, 1993
- Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.1993
- [Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay].1992
- [Mass screening of stomach neoplasms by serum pepsinogen analysis].1992
- [Estimation of frequency, population doses and stochastic risks in stomach mass screening examinations in Japan, 1980].1987
- Serum pepsinogens I and II and stomach cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disordersClinica Chimica Acta; International Journal of Clinical Chemistry, 1982
- RELATIONSHIPS AMONG SERUM PEPSINOGEN-I, SERUM PEPSINOGEN-II, AND GASTRIC-MUCOSAL HISTOLOGY - A STUDY IN RELATIVES OF PATIENTS WITH PERNICIOUS-ANEMIA1982